[Clinical trials in Germany. The gastroenterologist in private practice as a partner in clinical trials].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to B Bokemeyer.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
BACKGROUND AND OBJECTIVE: Elevated serum lipase and amylase are often observed in IBD patients (Crohn's disease and ulcerative colitis) without clinical symptoms of a pancreatitis. The intention of this prospective study is to evaluate the frequency of elevated serum lipase and amylase with these patients and to try to explain this phenomenon in consideration of the existing literature. PATIENTS AND METHODS: 136 IBD patients (MC: 66; CU: 70) participated in this prospective study which lasted 3 months. All patients with increased levels of serum lipase and amylase were prospectively followed-up for another 3 months. RESULTS: We found an asymptomatic elevation of serum lipase and amylase without symptoms of a pancreatitis in 14 % of the observed IBD patients. A significance between the elevation of lipase/amylase and the activity index (CDAI,CAI) or the CRP level could not be found. A significant increase of lipase/amylase (more than twice the normal standard) was shown more often in lipase (4.4 %) than in amylase levels (0.7 %). The possible reasons for an asymptomatic increase of lipase/amylase in IBD patients (e. g. latent extra-intestinal involvement of the pancreas in IBD with pancreatitis; extra-pancreatic release of lipase/amylase from the inflammatory bowel; intestinal reabsorption of released lipase/amylase in the inflammatory bowel) are discussed in this text. CONCLUSION: An asymptomatic elevation of lipase/amylase in IBD patients is not infrequent (14 %). The increase of lipase or amylase, without typical symptoms, makes a pancreatitis with a required therapy unlikely. A specific pancreatitis therapy is not necessary in these cases. The therapy should be guided by the requirements of the IBD therapy.
Explore the source record for details and available documents.
The case of a patient with diffuse white furs in the whole esophagus is described. Esophagoscopy was suggestive of the presence of a wide-spread Candida esophagitis. The histologic and cultural examinations excluded Candida esophagitis and did not show unequivocal pathologic alterations. Detailed anamnestic exploration revealed a long existing distinct abuse of an antacid. After discontinuation of the antacid-intake a control gastroscopy was done 4 months later showing completely normal mucosa and disappearance of all furs. The present case demonstrates that antacidum intake must be encountered as differential diagnosis of esophageal white plaques.
Explore the source record for details and available documents.
Two-hundred and ten consecutive patients undergoing routine gastroscopy were additionally investigated for evidence of Campylobacter pylori (C.p.). 106 patients were positive in one or more tests: 99.1% using a rapid urease detecting test (CLO-test), 80.2% histology, 78.3% cytology and 60% culture. We found no difference between the CLO-test results from biopsies taken from different parts of the stomach in individual patients. C.p. was found in 100% of patients with significant chronic antral gastritis, 67.7% with gastric ulcers, 65% with duodenal ulcers and in 12.1% of normal individuals. The C.p. infection was apparently eliminated in 50% of cases treated with bismuth subsalicylate (BSS) for four weeks. The combination of BSS with amoxicillin, tinidazole or an H2-receptor antagonist offered no advantage over BSS alone. Treatment with BSS led to improvement in symptoms and histological findings including healing of ulcers in patients with or without persistent C.p. infection. The recurrence of C.p. infection after apparently successful treatment was, however, 75% in 4 weeks. In conclusion, C.p. infection correlates strongly with the presence of chronic gastritis, and significantly with gastric and duodenal ulceration. The best diagnostic approach is the combination of a rapid urease detecting test and histology. C.p. infection is of long duration and difficult to eliminate. The most effective treatment for C.p. infection remains BSS as single agent.
The therapeutic effect of combined chemoembolization with lipiodol, epirubicin and cisplatin in 22 patients with nonresectable tumours, predominantly in livers with cirrhotic transformation, was analysed. Lipiodol was demonstrated in tumour tissue on average three months, maximally six months, after injection. Repeat embolization was done, if possible, after storage had subsided. There were only minor side effects. Quality of life suffered only from the, though delayed, continuing cancer growth. Survival rate was 73% after six months, 54% after one year.
The case of a patient suffering from multifocal idiopathic stenosing enteritis is described. The clinical picture is characterized by a recurrent ileus-symptomatology, which is conditioned by multiple strictures of the small bowel with a considerable dilatation of the inserted small bowel segments, by a differently marked malabsorption syndrome and by an intermittent clinical course. Aspects of the differential diagnosis are discussed, especially in relation to the non-granulomatous ulcerative jejuno-ileitis.
Using a grouping method we studied the disease homogeneity within a group of 109 patients with systemic lupus erythematosus. The mean observation period was 6 years and 8 months. By using a cluster analysis, the total group of patients could be subdivided into two subgroups which differed clearly in their symptomatology. One subgroup (n = 42) showed higher incidence of elevated serum creatinine values, proteinuria, oral ulceration and severe anaemia. All 13 deaths occurred in this group. The second group (n = 67) was characterized by a more benign course of disease, a notably decreased incidence of renal involvement, and the Raynaud's Phenomenon was comparatively frequent.
Explore the source record for details and available documents.
Using a grouping method the disease homogeneity within a group of 59 patients with systemic lupus erythematosus was studied. The mean observation period was 8 years and 10 months. By using a cluster analysis, the total group of patients could be divided into two subgroups which differed clearly in their symptomatology. One subgroup showed a higher incidence of hypertension, severe anaemia, oral ulceration, elevated serum creatinine values, and proteinuria. All 8 deaths occurred in this group. The second group was characterized by a more benign course of disease, a notably decreased incidence of symptoms characteristic for the first subgroup, and no deaths.